Meditech Research Ltd.

BrightView Health, a behavioral health facility that specializes in addiction treatment and substance abuse, already was using telehealth when the COVID-19 pandemic and associated response happened. The organization mostly was using telehealth between its various locations. THE PROBLEM However, BrightView did not have a secure communications platform to engage with patients either synchronously or asynchronously. "So, the pandemic and the lockdowns created some potential gaps in access to care that we needed to predict and fill," said Navdeep S. Kang, chief clinical officer at BrightView Health and a fellow with the Obama Foundation. "We looked at several platforms to implement secure communications. "We were specifically interested in technology that would allow us to do one-to-one visits that we could sequence with a 'waiting room' functionality that enables members of the care team to go in and out of patient visits and allows for group services," he continued. "And we needed something that would be easy for patients to use. So, technology that would work on everyone's phones, including staff and patients." Because of the pandemic, some patients had problems finding transportation options because the response to COVID resulted in a reduction in other services that often facilitated patients' access to transportation – such as fewer available Uber rides or taxis. And this further reduced their ability to access care and hampered achievement of their treatment plans. "We needed to do something new, something we hadn't done before, which would enable secure and seamless telehealth while ensuring access to and retention of care, while reducing risk to patient engagement," Kang explained. "In behavioral health and addiction treatment, duration matters, so we needed to maintain the connections." PROPOSAL BrightView had used a telehealth technology for two or three months. It had limited functionality and was more of a survival tactic to get things up and running – pushing it out to the team and getting them to reach out to the patients who couldn't leave the house. But the organization kept testing a variety of platforms and opted for a more thoughtful and thorough approach, Kang said. He said they particularly needed a system that was HIPPA-compliant and easy for any patient to use. "We needed to do something new, something we hadn't done before, which would enable secure and seamless telehealth while ensuring access to and retention of care, while reducing risk to patient engagement." Navdeep S. Kang, PsyD, BrightView Health "What was unique about DrFirst's Backline was the combination of ways to communicate – how it enables the team to interact with the patients and with each other," he noted of the vendor they decided to run with. "Plus, its ability to integrate with our Meditech EHR . "The admission-discharge-transfer feed has been essential to freeing licensed clinical resources who are usually tasked with pulling a patient's clinical information, allowing them to focus on patient care," he added. Kang referred to the new technology set-up as magical, but added staff should expect this level of sophistication in behavioral health, which is still not where the rest of healthcare is with regard to technology. "Technology that does all the functional ADT processes and is integrated with our EHR allows us to pull patient information directly in," he added. MEETING THE CHALLENGE The counseling and nursing teams use Backline more than medical staff because the medical staff tends to see patients mostly in person. But both teams can use the technology to communicate with the patient either outside of their typical medical visit cadence, or in between for counseling. If the patient is seeing the medical staff once every two weeks, they're seeing their counselor every week. "The patient can use the platform outside of their in-office medical visits," Kang said. "That way, they don't need to use a ride share or their insurance benefit or ask their neighbor to watch their kids if their counselor can still provide them with the service virtually. "We also have an opioid treatment program where we provide medication to the patient," he continued. "And the nursing team does patient education – how to properly store and use medication, how to keep it safe. They also provide infectious disease education and other counseling through the technology, which, again, also happens in person but can be easily done as needed through the technology." RESULTS BrightView has not cut its data to reflect only the results of those who have used Backline versus those who have not. But it does have a robust outcomes dashboard through which it tracks patient progress longitudinally over time. "Our telehealth visit and chat metrics do reflect the increased level of interaction between care teams and patients since we started using Backline in 2020," Kang reported. "For example, we had more than 1,300 telehealth visits as of November 2022, more than twice the number for all of 2021. And we are logging more than 150,000 chat feeds in 2021 and 2022. "Backline has allowed us to increase patient access to outpatient care and extend our reach into as many communities as possible," he added. ADVICE FOR OTHERS "You must be mindful of the intended goal," Kang advised. "What are you trying to achieve by adopting the technology? Without intentionality, a few things can happen. One, you have a bunch of technology that you throw at your staff and at your patients, and that just leads to inadequate adoption, and wastes a lot of energy and money. "You need to be clear on your needs and what you want to accomplish," he continued. "You then need to thoroughly understand the distinct capabilities of different technologies and match your needs to correct technology. What are you trying to accomplish? Be clear with that." And then, whether one goes through a formal RFP or other process, make sure one's team has an opportunity to fully evaluate functionality, and determine who delivers it best. "Recruit volunteers to do testing and use that opportunity to gain feedback from folks who are the end users," Kang said. "Also, when you're training staff on the new technology, whether you're talking to the staff or to the patients, make sure the value proposition is clear. "Why should we use this?" he concluded. "How will it impact care? Clinicians care about the patients getting better, and they care about value and quality. Patients obviously care about the same. So be clear on what the new technology does and its value to their role." Follow Bill's HIT coverage on LinkedIn: Bill Siwicki Email the writer: bsiwicki@himss.org Healthcare IT News is a HIMSS Media publication.

DUBLIN--( BUSINESS WIRE )--The "Intrauterine Insemination (IUI) Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (IUI Catheters v/s IUI Media/Sperm Wash), By End User (Hospitals, IVF Centers & Clinics, Others), and By Region" report has been added to ResearchAndMarkets.com's offering. The global intrauterine insemination (IUI) devices market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rise in infertility rate, and advancements in healthcare facilities are driving the growth of the global intrauterine insemination (IUI) devices market. Intrauterine insemination (IUI) is a kind of fertility treatment that is aimed at increasing the rate of fertilization by increasing the number of sperms in women's uterus. The Intrauterine Insemination (IUI) is minimally invasive and cost-effective first-line therapy for patients compared to other fertility treatment options. The other factors such as the increasing government investments, rising awareness among the masses, products for home care setting for treatment, new government regulations, and technological advancements, are expected to bolster the global intrauterine insemination (IUI) devices market growth over the next five years Rise in Infertility Rate Over the past few years, a constant rise in infertility rate is reported as people are suffering from diseases such as erectile dysfunction and Polycystic Ovary Syndrome (PCOS). The change in lifestyle, and also people wanting children later in their life may lead them into some complications. According to the National Women's Health Resource Center, infertility affects nearly 20 million women. In 2017, United Nations World Population Prospects report speculated that the total fertility rate would decline from 2.43 to 2.39 (children per woman) between the years 2020 and 2030. This growing incidences of infertility among the world's population is propelling the Intrauterine Insemination (IUI) Devices market forward. Rising Awareness and various initiatives by Governments Nowadays, people are becoming more aware of the Intrauterine Insemination procedure, owing to the awareness efforts presented by the public health foundations, the demand of these devices are bolstering the market growth. Furthermore, governments of respective countries are taking various initiatives, which is driving the market growth, globally. For instance, in 2020 the Union Cabinet of India approved Assistive Reproductive Technology Regulation Bill 2020 to regulate clinics providing safe and ethical ART services to infertile couples. Various modifications in laws by governments favoring same sex couples and single parents is going to influence the market growth. Advancements in Healthcare Facilities The technological advancement in the Intrauterine Insemination (IUI) technique is increasing the chances to conceive. These developments are done to make them more effective. Technological advances in automation and AI allows higher success rates by monitoring hormonal levels along with other health parameters, which augments the market growth in the approaching years. Moreover, several emerging FemTech companies are now providing market specific products and have hence presented opportunities for market development of intrauterine insemination devices. For instance, in June 2018, GE Healthcare (US) and Vitrolife AB partnered to improve patient outcomes in assisted reproductive technology. Market Segmentation United States is expected to be a lucrative market in the forecast period due to rise in infertility rate in the country. Competitive Landscape Company Profiles: Detailed analysis of the major companies present in Intrauterine Insemination (IUI) Devices Market Kitazato Corporation Gynotec B.V. Rocket Medical plc. CooperSurgical, Inc. Cook Group Inc. Prince Medical SAS Surgimedik Healthcare India Private Limited MedGyn Products, Inc. MediTech Devices Pvt. Ltd. Biorad Medisys Pvt. Ltd. Report Scope: Intrauterine Insemination (IUI) Devices Market, By Products: IUI Catheters Curved Flexible Straight IUI Media/Sperm Wash Intrauterine Insemination (IUI) Devices Market, By End User: Hospitals IVF Centers & Clinics Others Intrauterine Insemination (IUI) Devices Market, By Region: North America United States Canada Mexico Asia-Pacific China India Japan Australia South Korea Europe & CIS Germany France United Kingdom Spain Italy South America Brazil Argentina Colombia Middle East & Africa South Africa Saudi Arabia UAE For more information about this report visit https://www.researchandmarkets.com/r/j54ipb About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.